Geode Capital Management
ANVS icon

Geode Capital Management’s Annovis Bio ANVS Stock Holding History

Geode Capital Management’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$528K Buy
283,817
+36,304
+15% +$70.6K ﹤0.01% 3581
2026
Q1 		$552K Buy
247,513
+25,381
+11% +$69.6K ﹤0.01% 3554
2025
Q4 		$769K Buy
222,132
+37,978
+21% +$114K ﹤0.01% 3454
2025
Q3 		$381K Buy
184,154
+867
+0.5% +$2.17K ﹤0.01% 3716
2025
Q2 		$398K Buy
183,287
+30,674
+20% +$60.5K ﹤0.01% 3629
2025
Q1 		$229K Buy
152,613
+53,049
+53% +$162K ﹤0.01% 3796
2024
Q4 		$501K Buy
99,564
+450
+0.5% +$3.26K ﹤0.01% 3602
2024
Q3 		$799K Buy
99,114
+22,881
+30% +$214K ﹤0.01% 3430
2024
Q2 		$439K Buy
76,233
+5,442
+8% +$44.1K ﹤0.01% 3608
2024
Q1 		$843K Buy
70,791
+2,015
+3% +$22K ﹤0.01% 3425
2023
Q4 		$1.29M Buy
68,776
+12,736
+23% +$113K ﹤0.01% 3247
2023
Q3 		$532K Buy
56,040
+4,390
+8% +$54.3K ﹤0.01% 3580
2023
Q2 		$738K Hold
51,650
– – ﹤0.01% 3472
2023
Q1 		$796K Buy
51,650
+8,092
+19% +$131K ﹤0.01% 3446
2022
Q4 		$584K Buy
43,558
+1,262
+3% +$15.8K ﹤0.01% 3592
2022
Q3 		$579K Hold
42,296
– – ﹤0.01% 3646
2022
Q2 		$479K Buy
42,296
+269
+0.6% +$2.94K ﹤0.01% 3788
2022
Q1 		$561K Buy
42,027
+1,082
+3% +$15.6K ﹤0.01% 3878
2021
Q4 		$719K Hold
40,945
– – ﹤0.01% 3868
2021
Q3 		$1.3M Buy
40,945
+2,376
+6% +$137K ﹤0.01% 3551
2021
Q2 		$3.3M Buy
38,569
+10,986
+40% +$508K ﹤0.01% 3116
2021
Q1 		$769K Buy
+27,583
New +$590K ﹤0.01% 3663

Other funds holding ANVS

EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management's ANVS Position: Q2 2026 in Review

Geode Capital Management increased its Annovis Bio (ANVS) stake by 15% in Q2 2026, buying an estimated $70.6K and bringing the position to 283,817 shares worth $528K. The position accounts for ﹤0.01% of the portfolio, ranked #3581.

Geode Capital Management first reported a position in ANVS in Q1 2021 and has held it in 22 quarters since. The position peaked at $3.3M in Q2 2021. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • Geode Capital Management held 283,817 shares of Annovis Bio worth $528K as of Q2 2026.
  • Geode Capital Management bought 36,304 Annovis Bio shares in Q2 2026, an estimated $70.6K.
  • Annovis Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3581 holding.
  • Geode Capital Management first reported a position in Annovis Bio in Q1 2021 and has held it in 22 quarters since.
  • Geode Capital Management's Annovis Bio position peaked at $3.3M in Q2 2021.
  • 61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.